Th1 cytokines in oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 32, Issue 2, 2003, Pages 77-83

  Khan, Ambereen ^a   Farah, Camile S ^a   Savage, Neil W ^a   Walsh, Laurence J ^a   Harbrow, Doug J ^a   Sugerman, Philip B ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Cytokines; Oral lichen planus; Receptors

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LICHEN PLANUS; MALE; MONONUCLEAR CELL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

ADOLESCENT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; KERATINOCYTES; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037687892     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2003.00077.x     Document Type: Article

References (44)

1. Bowers KE, Sexton J, Sugerman PB. Commentary. Clin Dermatol 2000; 18: 497-8.
2. Hashimoto K. Apoptosis in lichen planus and several other dermatoses. Acta Dermatol Venereol 1976; 56: 187-210.
3. Weedon D. Apoptosis in lichen planus. Clin Exp Dermatol 1980; 5: 425-30.
4. Dekker NP, Lozada-Nur F, Lagenaur LA, et al. Apoptosis-associated markers in oral lichen planus. J Oral Pathol Med 1997; 26: 170-5.
5. Shimizu M, Higaki M, Kawashima M. The role of granzyme B-expressing CD8-positive T cells in apoptosis of keratinocytes in lichen planus. Arch Dermatol Res 1997; 289: 527-32.
6. Neppelberg E, Johannessen AC, Jonsson R. Apoptosis in oral lichen planus. Eur J Oral Sci 2001; 109: 361-4.
7. Sugerman PB, Satterwhite K, Bigby M. Auto-cytotoxic T cell clones in lichen planus. Br J Dermatol 2000; 142: 449-56.
8. Sugerman PB, Savage NW, Seymour GJ. Clonal expansion of lymphocytes from oral lichen planus lesions. J Oral Pathol Med 1993; 22: 126-31.
9. Kilpi AM. Activation marker analysis of mononuclear cell infiltrates of oral lichen planus in situ. Scand J Dent Res 1987; 95: 174-80.
10. Jungell P, Konttinen YT, Nortamo P, et al. Immunoelectron microscopic study of distribution of T cell subsets in oral lichen planus. Scand J Dent Res 1989; 97: 361-7.
11. Sugerman PB, Savage NW, Zhou X, Walsh LJ, Bigby M. Oral lichen planus. Clin Dermatol 2000; 18: 533-9.
12. Sugerman PB, Savage NW, Seymour GJ, Walsh LJ. Is there a role for tumour necrosis factor alpha (TNF-α) in oral lichen planus? J Oral Pathol Med 1996; 25: 219-24.
13. Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2-4-10, tumour necrosis factor-α and transforming growth factor-β mRNAs in oral lichen planus. Arch Oral Biol 1999; 44: 499-507.
14. Walsh LJ, Davis MF, Xu LJ, Savage NW. Relationship between mast cell degranulation and inflammation in the oral cavity. J Oral Pathol Med 1995; 24: 266-72.
15. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM. Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 1993; 94: 354-62.
16. Matthews JB, Scully CM, Potts AJ. Oral lichen planus: an immunoperoxidase study using monoclonal antibodies to lymphocyte subsets. Br J Dermatol 1984; 111: 587-95.
17. Ishii T. Immunohistochemical demonstration of T cell subsets and accessory cells in oral lichen planus. J Oral Pathol 1987; 16: 356-61.
18. Kilpi AM. Characterization of mononuclear cells of inflammatory infiltrates in oral tissues. A histochemical and immunohistochemical study of labial salivary glands in Sjögren's syndrome and of oral lesions in systemic lupus erythematosus and in lichen planus. Proc Finn Dent Soc 1988; 84: 5-93.
19. Sugerman PB, Savage NW, Seymour GJ. Phenotype and suppressor activity of T lymphocyte clones extracted from lesions of oral lichen planus. Br J Dermatol 1994; 131: 319-24.
20. Rich AM, Reade PC. A quantitative assessment of Langerhans cells in oral mucosal lichen planus and leukoplakia. Br J Dermatol 1989; 120: 223-8.
21. Farthing PM, Matear P, Cruchley AT. The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med 1990; 19: 81-5.
22. Farthing PM, Cruchley AT. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus. J Oral Pathol Med 1989; 18: 305-9.
23. Walsh LJ, Ishii T, Savage NW, Gemmell E, Seymour GJ. Immunohistologic analysis of epithelial cell populations in oral lichen planus. J Oral Pathol Med 1990; 19: 177-81.
24. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15: 297-322.
25. Muller G, Saloga J, Germann T, et al. Identification and induction of human keratinocyte-derived IL-12. J Clin Invest 1994; 94: 1799-805.
26. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH. IL-12 synthesis by human Langerhans cells. J Immunol 1996; 156: 1402-7.
27. Simark Mattsson C, Jontell M, Bergenholtz G, Heyden M, Dahlgren UI. Distribution of interferon-gamma mRNA-positive cells in oral lichen planus lesions. J Oral Pathol Med 1998; 27: 483-8.
28. Flanders KC, Roberts AB. TGF. In: Feldmann, M, Durum, SK, Hirano, T, Vilcek, J, Nicola, NA, eds. Cytokine Reference. A Compendium of Cytokines and Other Mediators of Host Defense. San Diego: Academic Press, 2001: 719-46.
29. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996; 98: 70-7.
30. Bridoux F, Badou A, Saoudi A, et al. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J Exp Med 1997; 185: 1769-75.
31. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 1998; 10: 649-55.
32. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998; 16: 137-61.
33. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753-91.
34. Blobe GC, Liu X, Fang SJ, How T, Lodish HF. A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem 2001; 276: 39608-17.
35. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-9.
36. Dang H, Geiser AG, Letterio JJ, et al. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol 1995; 155: 3205-12.
37. Yang X, Letterio JJ, Lechleider RJ, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999; 18: 1280-91.
38. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 1999; 397: 710-3.
39. Strober W, Kelsall B, Fuss I, et al. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 1997; 18: 61-4.
40. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB. Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J Cell Biol 1989; 108: 661-9.
41. Gorelik L, Flavell RA. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells. Nature Med 2001; 7: 1118-22.
42. Pasche B. Role of transforming growth factor beta in cancer. J Cell Physiol 2001; 186: 153-68.
43. Akhurst RJ, Fee F, Balmain A. Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis. Nature 1998; 331: 363-5.
44. Cui W, Fowlis DJ, Bryson S, et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996; 86: 531-42.